Welcome to our dedicated page for Versigent news (Ticker: VGNT), a resource for investors and traders seeking the latest updates and insights on Versigent stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Versigent's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Versigent's position in the market.
Versigent (NYSE: VGNT) launched as an independent public company on April 1, 2026, following a tax-free spin-off from Aptiv. Shares begin trading under VGNT and leadership rang the NYSE Opening Bell.
Versigent starts with $8.8B revenue, $528M net income, and $893M adjusted EBITDA for 2025, expects >3% top-line growth, plans >200 bps EBITDA margin expansion over three years, and targets $1B free cash flow by 2028. Distribution: one Versigent share per three Aptiv shares; fractional-share cash paid. First-quarter results due May 5, 2026.
Aptiv (NYSE: APTV) will release Q1 2026 financial results on May 5, 2026 prior to market open and hold an investor call at 8:00 a.m. ET. Results will report Total Aptiv with Electrical Distribution Systems (EDS) as a segment.
Versigent (NYSE: VGNT), the EDS carve-out expected to spin off on April 1, 2026, will release Q1 2026 results on May 5, 2026 following market close and host a call at 4:15 p.m. ET. Webcasts, presentation materials, replays, and dial-in details are available on each company’s investor relations site.